8 Coupons
-
Special Offer
-
30% off
-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
-
..
it also provides 85 per cent accurate prediction results than current methods. . ..
.